FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/15/2022
Back to search
Official data from USPTO
MABXMISE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MABXMISE
ST13
US500000079292587Class
1, 5, 41, 42, 44
Filing
79292587
Registration
6549567
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
09/02/2022
Trademark type
Word
Nice classes
1, 5, 41, 42, 44
Filing date
01/27/2020
Registration date
11/09/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/09/2021
Last transaction
09/02/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
FR
Examiner
MASULLO, MARCO
Law office
N50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
P. P. (pessoa física)
Representatives
Rebeccah Gan Muncy, Geissler, Olds & Lowe, P.C.
Technical classification
Nice Classes
Class 1Class 5Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals for use in industry and sciencenot for medical usebiochemical catalystsbiochemical reagents used for non-medical purposesbiochemical preparations for scientific purposesbiological preparations for use in industry and science; proteins for industrial usein raw materials form for scientific and medical research; diagnostic preparations used in science; diagnostic reagents and preparationsexcept for medical or veterinary use; immunohistochemistry detection kits consisting of mouse secondary reagentsDAB chromogensDAB buffersperoxidase blocking reagenthematoxylinfor anatomic pathology purposes in the medical diagnostics industry
Class 5
Medicated skin care preparations; medicated skin care preparations for veterinary use; diagnostic preparations for veterinary purposeschemical reagents for medical or veterinary purposes; proteins for medical or veterinary useprotein arrays for medical diagnosis purposes; diagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testing; drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids
Class 41
Educational servicesproviding tutorial sessionspanel discussionsnon-downloadable webinarsseminarstraining in the fields of pharmaceuticals and biotechnology; publishing of booksmanualsmagazinescomputer data intended for use on a computer or telephone network; electronic publishing servicespublication of text and graphic works of others on CD-ROMs in the fields of pharmaceuticals and biotechnology; organizing and conducting colloquiumsconferences and congresses in the fields of pharmaceuticals and biotechnology; organization of exhibitions for cultural or educational purposes; organization of events for cultural purposes; organizing events in the fields of pharmaceuticals and biotechnology for educational purposes
Class 42
Scientific and industrial research in the fields of chemistrybiochemistrybiotechnology and biology; computer programmingdesigndevelopmentrentalupdating and maintenance of software; engineering services in the nature of the provision of expert reports in the field of chemistrybiochemistrybiotechnologies and biology; technical adviceconsultation and information all in the fields of biochemistrybiotechnologies and biologytechnical support and advice for drawing updeveloping and implementing protein chemistryprotein biochemistrybiotechnologies and protein biology methodsprotocolsprocedures; material testingtesting of chemicalbiochemicalbiotechnology and biological materials and substances; research services in the chemicalbiochemicalbiotechnological and biological fields provided in laboratories; therapeutic strategies research and development servicesresearch and development in the pharmaceutical and biotechnology fields
Class 44
Medical services; veterinary services; medical analysis services in relation to the treatment of individualsx-ray examinations for medical purposesmedical testing of bloodmedical testing of urinebloodhair follicles and breathmedical imaging servicesmedical testing for diagnostic or treatment purposes; DNA screening for medical purposes
Publications
History of USPTO decisions and trademark events.
40 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/27/2022
FIMP
FINAL DISPOSITION PROCESSED
04/27/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/09/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/27/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/27/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/27/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/27/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/27/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/16/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
12/16/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/16/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/16/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
11/09/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/24/2021
PUBO
PUBLISHED FOR OPPOSITION
08/24/2021
GPNX
NOTIFICATION PROCESSED BY IB
08/22/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/04/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/04/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/04/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/20/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/27/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/26/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
04/26/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
04/01/2021
GNFR
FINAL REFUSAL E-MAILED
04/01/2021
CNFR
FINAL REFUSAL WRITTEN
04/01/2021
DOCK
ASSIGNED TO EXAMINER
02/02/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/17/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/16/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/16/2020
RFNT
REFUSAL PROCESSED BY IB
10/19/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/28/2020
RFRR
REFUSAL PROCESSED BY MPU
09/28/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/09/2020
CNRT
NON-FINAL ACTION WRITTEN
09/08/2020
MAFR
APPLICATION FILING RECEIPT MAILED
09/01/2020
DOCK
ASSIGNED TO EXAMINER
08/28/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/28/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/27/2020
Continuous trademark protection
Get notified about every new filing that threatens MABXMISE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.